$BIO

AI 分析

生成于 May 11, 2026

AI Score
56/ 100
Hold$BIO

Bio-Rad Laboratories

$BIONYSEHealthcareLarge-Cap

Bio-Rad manufactures and sells clinical diagnostics products and life science research instruments globally.

Market Cap
$8.0B
Revenue (TTM)
$2.5B
-5.0%
Net Income (TTM)
$0.15B
-20.0%
EPS (TTM)
$5.00
P/E Ratio
62.0
Dividend Yield
0.0%
52-Week Range
$260-$420
Beta
0.62
Dimension Scores
Fundamental
54
Technical
52
Sentiment
58
Risk / Reward
60
Momentum
48
FundTechSentRiskMome
Financial Health
Profitability
59moderate
Growth
51weak
Liquidity
68strong
Solvency
56moderate
Efficiency
52moderate

Valuation, technical analysis, investment thesis, risk assessment and more for $BIO

Free · No credit card required

免责声明: AI 生成的分析仅供教育参考,不构成投资建议。请始终咨询合格的理财顾问。

探索更多

用 AI 分析任意股票

获取涵盖基本面、技术面、情绪面、风险评估和投资论点的结构化研究报告——约 60 秒完成。